Literature DB >> 14690066

The epidemiology and definition of the acute respiratory distress syndrome.

Margaret J Neff1.   

Abstract

Acute lung injury and ARDS have been clinically recognized syndromes for nearly 30 years. During that time, the understanding of the risks, pathophysiology, and outcomes has changed and improved. The definition for this disease has evolved in an attempt to identify more accurately and reliably a more homogeneous patient population that could be expected to have similar responses to the disease and therapies. The most widely accepted definition is that developed by the AECC in 1994 and now commonly used in epidemiologic studies and clinical trials. Estimates of the incidence of the disease and of mortality are significantly affected by variability in definitions used. Current estimates of the incidence of ALI, however, range from 3 to 75 cases/100,000 population/year. Mortality estimates range from 30% to 40%. Although mortality has improved from more than 60% 20 years ago, ALI survivors are still faced with an increased risk of death as well as significant decrements in physical function and quality of life through the first 12 months after hospital discharge. A great deal of progress has been made in the understanding and management of ALI patients. Now, as the search for new therapeutic options continues, equal attention must be focused on studying and improving qualitative outcomes for this group of patients.

Entities:  

Mesh:

Year:  2003        PMID: 14690066     DOI: 10.1016/s1078-5337(03)00039-x

Source DB:  PubMed          Journal:  Respir Care Clin N Am        ISSN: 1078-5337


  4 in total

1.  The search for "objective" criteria of ARDS.

Authors:  Daniel P Schuster
Journal:  Intensive Care Med       Date:  2007-01-13       Impact factor: 17.440

2.  The clinical usefulness of extravascular lung water and pulmonary vascular permeability index to diagnose and characterize pulmonary edema: a prospective multicenter study on the quantitative differential diagnostic definition for acute lung injury/acute respiratory distress syndrome.

Authors:  Shigeki Kushimoto; Yasuhiko Taira; Yasuhide Kitazawa; Kazuo Okuchi; Teruo Sakamoto; Hiroyasu Ishikura; Tomoyuki Endo; Satoshi Yamanouchi; Takashi Tagami; Junko Yamaguchi; Kazuhide Yoshikawa; Manabu Sugita; Yoichi Kase; Takashi Kanemura; Hiroyuki Takahashi; Yuichi Kuroki; Hiroo Izumino; Hiroshi Rinka; Ryutarou Seo; Makoto Takatori; Tadashi Kaneko; Toshiaki Nakamura; Takayuki Irahara; Nobuyuki Saito; Akihiro Watanabe
Journal:  Crit Care       Date:  2012-12-11       Impact factor: 9.097

3.  Hypoxia Inducible Factor-2 Alpha and Prolinhydroxylase 2 Polymorphisms in Patients with Acute Respiratory Distress Syndrome (ARDS).

Authors:  Annika Dötsch; Lewin Eisele; Miriam Rabeling; Katharina Rump; Kai Walstein; Alexandra Bick; Linda Cox; Andrea Engler; Hagen S Bachmann; Karl-Heinz Jöckel; Michael Adamzik; Jürgen Peters; Simon T Schäfer
Journal:  Int J Mol Sci       Date:  2017-06-14       Impact factor: 5.923

4.  Relationship between extravascular lung water and severity categories of acute respiratory distress syndrome by the Berlin definition.

Authors:  Shigeki Kushimoto; Tomoyuki Endo; Satoshi Yamanouchi; Teruo Sakamoto; Hiroyasu Ishikura; Yasuhide Kitazawa; Yasuhiko Taira; Kazuo Okuchi; Takashi Tagami; Akihiro Watanabe; Junko Yamaguchi; Kazuhide Yoshikawa; Manabu Sugita; Yoichi Kase; Takashi Kanemura; Hiroyuki Takahashi; Yuuichi Kuroki; Hiroo Izumino; Hiroshi Rinka; Ryutarou Seo; Makoto Takatori; Tadashi Kaneko; Toshiaki Nakamura; Takayuki Irahara; Nobuyuki Saito
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.